PredictImmune, a Cambridge spinout, added series B capital from investors including Cambridge Enterprise and CIC to $6.1m in series A funding raised last April.

Air Liquide and IMI-backed Quanta has raised an initial $48m for a series C round that will support the launch of its personal haemodialysis system.

Merck & Co co-led the round, which will help the health data software producer to further develop its AI-powered clinical data repository.

Chief executive Tomoko Inoue describes her unit’s core interests and how it interacts with entrepreneurs.

The healthcare provider's corporate VC unit, which has backed 15 companies and two funds, has put together a second fund that is the same size as its first.

Red Star Macalline has invested in drug manufacturing services provider Mingdu Intelligent as part of a round that will fund the latter's R&D marketing efforts.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Livongo priced its shares above their range to raise more than $355m, providing exits to Merck GHI, M12, Humana, Zaffre Investments and Echo Health Ventures.

Health Catalyst, which counts several care providers as investors, has raised $182m in its initial public offering, with its share price shooting up more than 50% on the first day of trading.

Harvard Medical School spinout TScan has come out of stealth with $48m in funding provided by investors including GV and two Novartis units.